85
Participants
Start Date
July 31, 2014
Primary Completion Date
June 30, 2016
Study Completion Date
June 30, 2016
NPH
NPH given per study table based on steroid dose and patient weight in kg.
Correction Factor
Given at 2 units per 50 mg/dl over 200 mg/dl and increased to 3 units/50 mg/dl over 200 if glucose rises to over 300 mg/dl. Administered qid during study duration.
Hennepin County Medical Center, Minneapolis
Lead Sponsor
Eli Lilly and Company
INDUSTRY
Hennepin Healthcare Research Institute
OTHER